Aerovate Therapeutics Inc (AVTE)
19.83
-1.73
(-8.02%)
USD |
NASDAQ |
May 10, 16:00
19.87
+0.04
(+0.20%)
After-Hours: 20:00
Aerovate Therapeutics Shareholders Equity (Quarterly): 109.46M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 109.46M |
| September 30, 2023 | 125.72M |
| June 30, 2023 | 141.93M |
| March 31, 2023 | 113.10M |
| December 31, 2022 | 126.74M |
| September 30, 2022 | 139.14M |
| June 30, 2022 | 151.05M |
| Date | Value |
|---|---|
| March 31, 2022 | 161.95M |
| December 31, 2021 | 172.42M |
| September 30, 2021 | 179.85M |
| June 30, 2021 | -21.58M |
| March 31, 2021 | -16.12M |
| December 31, 2020 | -13.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-21.58M
Minimum
Jun 2021
179.85M
Maximum
Sep 2021
105.41M
Average
126.74M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Insmed Inc | -464.81M |
| Annexon Inc | 250.56M |
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 127.42M |
| Total Liabilities (Quarterly) | 17.96M |